Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT07944209

Remimazolam Induction Methods in Robotic Cholecystectomy

Conditions: General Anesthesia, Cholecystectomy

Sex: All
Ages: 20 Years – 70 Years
Healthy volunteers: No
Phase: NA
Enrollment: 90
Sponsor: Korea University Guro Hospital

Location: Korea University Ansan Hospital Ansan Gyeonggi-do

Summary

This prospective randomized study compares two methods of remimazolam induction in adults aged 20 to 70 years scheduled for elective single-port robotic cholecystectomy: a single intravenous bolus of 0.2 mg/kg versus continuous intravenous infusion at 12 mg/kg/hour. The primary outcome is emergence time, from discontinuation of sevoflurane to recovery of consciousness defined as a Modified Observer's Assessment of Alertness/Sedation (MOAA/S) score of 5. Ninety participants were enrolled.

Eligibility Criteria

Inclusion Criteria: * Age 20 to 70 years * Scheduled for elective single-port robotic cholecystectomy Exclusion Criteria: * Known hypersensitivity to benzodiazepines or flumazenil * Substance use disorder * Preoperative total bilirubin greater than 3.0 mg/dL * Liver transaminase levels greater than twice the upper limit of normal within one week before surgery

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07944209). StuddyBuddy aggregates publicly available trial information.